Ramesh Vemulapalli is an Infectious Disease physician affiliated with Bayhealth Foundation. OpenAlex indexes 71 publications with 2,317 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Banning St
Suite 260, Eden Hill Medical Center
Dover, DE 199043485
Telephone
302-674-4627Registry record last updated 3 Jan 2018.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20254 payments
- Merck Sharp & Dohme LLCProgram year20254 payments
- Gilead Sciences, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
86.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor17.4%Tivicay42%Juluca23%Dovato15%Cabenuva10%Isentress10%Part D<11 patientsCephalosporin Antibacterial10%Ceftriaxone38%Cefepime Hcl27%Cefdinir20%Cefazolin Sodium15%Part D<11 patients+ 16 more classes in this area
Blood & clotting
5.4%Salt solutions5.4%Sodium Chloride100%Part D≥20 patientsAntiparasitic
3.4%Antimalarial3.4%Atovaquone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of three 5′ exonuclease–based real-time polymerase chain reaction assays for detection of pathogenic <i>Leptospira</i> species in canine urine
Journal of Veterinary Diagnostic Investigation
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Garrett Colmorgen, MD
Bayhealth Foundation
Gary Szydlowski, MD
Bayhealth Foundation
Michael Zaragoza, MD
Bayhealth Foundation
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”